PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV · Clinician

New Weight Loss Pill Approved by FDA: Wegovy Pill Explained by Obesity Doctor

Clinician15:20Dec 2025

Today’s cheapest semaglutide pill$199/mo at RxSpan MD on a 6-month plan.Compare all semaglutide pill prices Price read 14 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

In this video, the channel, who says she is a physician board certified in obesity medicine and also a nephrologist, discusses the FDA approval of the Wegovy pill. She describes it as the first semaglutide pill approved specifically for weight loss, noting that the earlier oral semaglutide, Rybelsus, was approved for diabetes. She says Novo Nordisk expects it to be available by January 2026.

Published by Dr. Frita on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

She summarizes the OASIS 4 trial, a randomized placebo-controlled study of 307 adults with obesity or overweight and no diabetes. According to her, people who took the 25 mg pill daily as directed for 64 weeks lost an average of 16.6% of body weight, versus 2.7% on placebo. Across everyone assigned to the pill, the average loss was 13.6%, versus about 2% on placebo. She notes that all participants also had a reduced calorie diet, dietitian counseling and exercise. She lists a starting dose of 1.5 mg, then 4 mg, 9 mg and 25 mg daily, an expected starting price of $149 a month, and side effects she describes as similar to the injection: nausea, diarrhea and constipation.

The second half focuses on medical supervision and stigma. She explains that reduced thirst can lead to dehydration, which she links to kidney failure and kidney stones, and says the FLOW trial correlated GLP-1 use with slower chronic kidney disease progression. She argues that obesity is a chronic condition, that treatment may need to be long term because many people regain weight after stopping semaglutide, and that using medication is not cheating. She advises against buying from unverified sellers or borrowing someone else's pills.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:31 The channel says the Wegovy pill is the first semaglutide pill FDA approved specifically for weight loss, unlike Rybelsus, which was approved for diabetes.
  2. 1:03 She reports that in the 307-adult OASIS 4 trial, people taking 25 mg daily for 64 weeks lost an average of 16.6% of body weight versus 2.7% on placebo.
  3. 2:34 She says the starting 1.5 mg dose is expected to cost $149 a month out of pocket, with doses rising to 4 mg, 9 mg and 25 mg daily.
  4. 4:36 She explains that reduced thirst can cause dehydration, which she links to kidney problems, and recommends physician supervision.
  5. 7:07 She says obesity is a chronic condition and that medication may need to be taken long term, since many people regain weight after stopping semaglutide.
  6. 12:47 She advises against buying GLP-1 medication from unverified sources or using someone else's supply, and says to use it under a doctor's supervision.

Key moments

Tap one to play from there.

  1. 0:00 New FDA approved pill
  2. 0:50 Oasis 4 trial results
  3. 2:47 Pricing and dosage details
  4. 3:59 Side effects and health benefits
  5. 4:59 Kidney health considerations
  6. 6:45 Trial summary and launch date
  7. 7:35 Addressing obesity stigma
  8. 10:57 Long-term management and care

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Wegovy and semaglutide
Side effects mentioned
dehydration

Questions this video answers

How much weight did people lose on the Wegovy pill in the OASIS 4 trial?

According to the channel, people who took the 25 mg pill daily as directed for 64 weeks lost an average of 16.6% of body weight, compared with 2.7% on placebo. Across everyone assigned to the pill, she says the average was 13.6%, versus about 2% on placebo.

What are the Wegovy pill doses and expected price?

She says dosing starts at 1.5 mg, then moves to 4 mg, 9 mg and 25 mg a day. She says the starting dose is expected to cost $149 a month out of pocket, and possibly less with insurance.

What side effects does the Wegovy pill have?

The channel says the side effects were very similar to the injection, including nausea, diarrhea and constipation in some people. She also says reduced thirst can lead to dehydration, so she recommends physician supervision.

Is the Wegovy pill different from Rybelsus?

She says both are oral semaglutide, but Rybelsus was approved for diabetes while the Wegovy pill is the first semaglutide pill approved specifically for weight loss.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • The best GLP-1 for weight loss, ranked by the evidence and then by the bill

    By weight lost, the order is settled: tirzepatide (Zepbound) first at 20.2% in the only head-to-head, then semaglutide 7.2 mg (Wegovy HD) at 18.7%, then semaglutide 2.4 mg (Wegovy) at 13.7% to 15.6%, then the pills. By what you pay, the order nearly inverts: compounded semaglutide from $39 a month, the Wegovy tablet from $149, Wegovy pen $349, Zepbound $299 to $699 by dose. The best one is where those two lists meet for your budget and your plan.

  • Is Hims legit? What its GLP-1 program costs, what reviews say, and its FDA record

    Yes. Hims & Hers is a real, licensed telehealth company, and as of October 2026 its weight-loss program sells FDA-approved brand-name GLP-1s: the Wegovy pill starts at $149 a month for the medication, plus a membership of $39 for the first month and $149 a month after, so about $298 a month from month two. It scores 2.9 on Trustpilot across 9,517 reviews, and FDA sent it a warning letter in September 2025 over compounded semaglutide marketing claims.

  • Wegovy 7.2 mg (Wegovy HD): what the higher dose adds, and what it costs

    Wegovy HD is semaglutide at 7.2 mg, three times the standard 2.4 mg dose, in its own pen. In the STEP UP trial it took 18.7% off body weight at 72 weeks against 15.6% for 2.4 mg and 3.9% for placebo, in 1,407 adults with obesity. That puts it within 1.5 points of tirzepatide's head-to-head result and makes it the strongest semaglutide there is. Novo sells it direct for $399 a month, $50 above the standard pen, and it sits above the normal ladder rather than replacing it.

Next steps

Wegovy pill prices

Find more like it

Side effectsDose changeFood noise and cravingsInjection techniqueCost and insuranceExercise and strengthAlcoholStopping and maintenanceThe trialsDehydration

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV